Characterization of Alzheimer's Disease and Mild Cognitive Impairment in Older Adults in Panama

J Alzheimers Dis. 2016 Oct 4;54(3):897-901. doi: 10.3233/JAD-160402.

Abstract

Research on age-related cognitive impairment is scarce in Central America. We report factors associated with cognitive impairment among a sample of older adults in Panama diagnosed with Alzheimer's disease (AD, n = 31), mild cognitive impairment (MCI, n = 43), or no cognitive impairment (controls, n = 185). Apolipoprotein E (ApoE) genotype was assessed in a subset of cases (n = 135). Age (OR = 2.53, 95% CI = 1.03-6.17) and ApoE ɛ4 (OR = 5.14, 95% CI = 2.11-12.52) were significantly related to cognitive impairment (AD/MCI combined). Results underscore the potential of genetic screening in Panama for identifying those at risk of dementia.

Keywords: Aging; Alzheimer’s disease; Latin America; apolipoprotein E; cognition; dementia; mild cognitive impairment.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, N.I.H., Extramural

MeSH terms

  • Aged
  • Aged, 80 and over
  • Aging / genetics*
  • Aging / psychology
  • Alzheimer Disease / diagnosis*
  • Alzheimer Disease / epidemiology
  • Alzheimer Disease / genetics*
  • Apolipoprotein E4 / genetics*
  • Cognitive Dysfunction / diagnosis*
  • Cognitive Dysfunction / epidemiology
  • Cognitive Dysfunction / genetics*
  • Female
  • Humans
  • Male
  • Neuropsychological Tests
  • Panama / epidemiology

Substances

  • Apolipoprotein E4